EXAS vs STEP · rev $2.76B vs rev $1.99B
EXACT Sciences Corporation (EXAS) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
EXAS currently screens at market cap $20.03B. STEP currently screens at market cap $5.78B.
Not investment advice. Open the EXAS and STEP stock pages for the full models.
Not investment advice.